Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
15.09
+0.27 (1.79%)
At close: Jun 5, 2025, 4:00 PM
15.11
+0.02 (0.17%)
After-hours: Jun 5, 2025, 4:04 PM EDT

Keros Therapeutics Market Cap

Keros Therapeutics has a market cap or net worth of $612.68 million as of June 5, 2025. Its market cap has decreased by -67.52% in one year.

Market Cap
612.68M
Enterprise Value
-89.65M
1-Year Change
-67.52%
Ranking
Category
Stock Price
$15.09

Market Cap Chart

Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $612.68M, an increase of 59.01%. That is a compound annual growth rate of 9.41%.

History

DateMarket Cap% Change
Jun 4, 2025601.92M-6.13%
Dec 31, 2024641.23M-46.17%
Dec 29, 20231.19B-9.94%
Dec 30, 20221.32B-3.39%
Dec 31, 20211.37B-16.27%
Dec 31, 20201.64B324.32%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 687.73B
Johnson & Johnson 368.61B
AbbVie 332.08B
Novo Nordisk 324.15B
UnitedHealth Group 272.60B
Abbott Laboratories 230.63B
Novartis AG 229.87B
AstraZeneca 226.47B
Market Cap Rankings